文献速递MDS 与骨髓增殖性肿瘤

JAK2 46/1单倍型影响PD-L1表达

The JAK2 46/1 haplotype influences PD-L1 expression.
PubMed 文献 · Blood · 2025-01-01

研究探讨JAK2 46/1单倍型增加JAK2突变骨髓增殖性肿瘤(MPN)风险的机制,发现46/1单倍型健康携带者及MPN患者CD34+细胞中PD-L1表达升高,PD-L1与邻近PD-L2位点以不同于非风险单倍型的方式与JAK2发生物理互作,CRISPR/Cas9编辑鉴定JAK2内含子2区域影响JAK2和PD-L1表达,作者认为PD-L1表达升高可能与46/1增加MPN遗传风险机制相关。

要点

  • 46/1单倍型健康携带者及MPN患者CD34+细胞中PD-L1表达升高。
  • PD-L1与邻近PD-L2位点以不同于非风险单倍型的方式与JAK2物理互作。
  • CRISPR/Cas9鉴定JAK2内含子2区域影响JAK2和PD-L1表达。

核心结论

  • 作者认为PD-L1表达升高可能与46/1单倍型导致MPN遗传风险增加的机制相关。

研究设计与样本

  • 研究比较46/1单倍型健康携带者与MPN患者CD34+细胞的PD-L1表达,采用环形染色体构象捕获观察PD-L1、PD-L2与JAK2的物理互作,并用CRISPR/Cas9基因组编辑鉴定JAK2内含子2区域。

主要发现

  • 46/1单倍型健康携带者及MPN患者CD34+细胞中PD-L1表达升高。
  • 环形染色体构象捕获显示PD-L1和邻近PD-L2位点与JAK2物理互作,且46/1与非风险单倍型间互作方式不同。
  • CRISPR/Cas9基因组编辑鉴定JAK2内含子2内一个区域影响JAK2和PD-L1表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although described more than a decade ago, the mechanism by which the JAK2 46/1 haplotype increases the risk of developing JAK2-mutated myeloproliferative neoplasms (MPNs) remains unexplained. Inflammation and immunity are linked to MPN development and thus could be relevant to the mechanism by which 46/1 mediates its effect. Here, we show that programmed death-1 receptor ligand (PD-L1) expression is elevated in 46/1 haplotype, both in healthy carriers and in CD34+ cells from patients with MPN. Using circular chromosome conformation capture, we observed that PD-L1 and the neighboring PD-L2 loci physically interact with JAK2 in a manner that differs between 46/1 and nonrisk haplotypes. CRISPR/Cas9 genome editing identified a region within JAK2 intron 2 that influences both JAK2 and PD-L1 expression. We suggest that increased PD-L1 expression may be relevant to the mechanism by which 46/1 leads to an increased inherited risk of developing MPN.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Carreño-Tarragona G, Tiana M, Rouco R, et al. The JAK2 46/1 haplotype influences PD-L1 expression. Blood. 2025. PMID: 39919265. doi:10.1182/blood.2023023787

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。